OC-0604 Early toxicity after SABR of oligometastatic bony metastases in the BONY M phase II trial. (May 2022) - Spindler, N.J.; Felter, M.V.O.; Hansen, O.; Nielsen, T.B.; Suppli, M.H.; Josipovic, M.; Poulsen, L.Ø.; Gaard-Petersen, F.; Sand, H.M.B.; Abramova, T.M.; Johansen, M.; Kornerup, J.S.; et al.